Aflac (AFL) Competitors

$84.83
+0.15 (+0.18%)
(As of 05/8/2024 ET)

AFL vs. CNC, HUM, PFG, PSA, SPG, O, TRV, MFG, MET, and IBKR

Should you be buying Aflac stock or one of its competitors? The main competitors of Aflac include Centene (CNC), Humana (HUM), Principal Financial Group (PFG), Public Storage (PSA), Simon Property Group (SPG), Realty Income (O), Travelers Companies (TRV), Mizuho Financial Group (MFG), MetLife (MET), and Interactive Brokers Group (IBKR).

Aflac vs.

Centene (NYSE:CNC) and Aflac (NYSE:AFL) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Centene received 442 more outperform votes than Aflac when rated by MarketBeat users. Likewise, 73.25% of users gave Centene an outperform vote while only 57.33% of users gave Aflac an outperform vote.

CompanyUnderperformOutperform
CenteneOutperform Votes
1013
73.25%
Underperform Votes
370
26.75%
AflacOutperform Votes
571
57.33%
Underperform Votes
425
42.67%

Aflac has a net margin of 27.67% compared to Aflac's net margin of 1.76%. Centene's return on equity of 16.88% beat Aflac's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene1.76% 14.19% 4.42%
Aflac 27.67%16.88%2.95%

Centene currently has a consensus target price of $85.23, indicating a potential upside of 12.35%. Aflac has a consensus target price of $82.31, indicating a potential downside of 2.97%. Given Aflac's stronger consensus rating and higher probable upside, analysts plainly believe Centene is more favorable than Aflac.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Aflac
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

In the previous week, Aflac had 5 more articles in the media than Centene. MarketBeat recorded 23 mentions for Aflac and 18 mentions for Centene. Centene's average media sentiment score of 0.90 beat Aflac's score of 0.73 indicating that Aflac is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
7 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Aflac
12 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.6% of Centene shares are held by institutional investors. Comparatively, 67.4% of Aflac shares are held by institutional investors. 0.3% of Centene shares are held by insiders. Comparatively, 0.8% of Aflac shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aflac has lower revenue, but higher earnings than Centene. Aflac is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$155.52B0.26$2.70B$5.0315.08
Aflac$18.70B2.58$4.66B$9.069.36

Centene has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Aflac has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500.

Summary

Centene and Aflac tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFL vs. The Competition

MetricAflacAccident & health insurance IndustryFinance SectorNYSE Exchange
Market Cap$48.20B$20.15B$8.97B$17.72B
Dividend Yield2.40%2.71%10.42%3.52%
P/E Ratio9.368.2157.2324.80
Price / Sales2.581.383,413.5610.75
Price / Cash10.698.9227.6915.59
Price / Book2.251.632.435.10
Net Income$4.66B$1.71B$995.87M$967.52M
7 Day Performance0.94%1.52%1.07%1.66%
1 Month Performance2.01%1.48%-0.24%-1.43%
1 Year Performance25.82%20.24%17.53%108.46%

Aflac Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNC
Centene
4.9018 of 5 stars
$75.90
+1.0%
$85.23
+12.3%
+11.1%$40.50B$154.00B15.0967,700
HUM
Humana
4.9934 of 5 stars
$324.63
+1.7%
$424.50
+30.8%
-39.5%$39.12B$106.37B20.2167,600
PFG
Principal Financial Group
3.633 of 5 stars
$82.46
-0.2%
$80.30
-2.6%
+16.2%$19.33B$13.67B15.7419,800Positive News
PSA
Public Storage
4.8077 of 5 stars
$273.32
+1.5%
$305.00
+11.6%
-9.5%$48.02B$4.52B24.826,200Dividend Announcement
SPG
Simon Property Group
3.736 of 5 stars
$147.95
+2.4%
$140.22
-5.2%
+36.9%$48.22B$5.66B21.203,000Earnings Report
Dividend Increase
Analyst Revision
O
Realty Income
4.3326 of 5 stars
$55.02
-0.8%
$60.96
+10.8%
-12.7%$47.38B$4.08B43.67418Earnings Report
TRV
Travelers Companies
4.8019 of 5 stars
$216.97
+0.5%
$223.47
+3.0%
+19.0%$49.68B$41.36B16.1233,300Analyst Revision
MFG
Mizuho Financial Group
3.525 of 5 stars
$3.91
-1.8%
N/A+31.8%$50.39B$2.88T10.8551,212
MET
MetLife
4.8928 of 5 stars
$71.26
+0.1%
$79.00
+10.9%
+33.5%$50.67B$66.91B24.4945,000Ex-Dividend
Analyst Forecast
Buyback Announcement
IBKR
Interactive Brokers Group
3.5876 of 5 stars
$120.54
-1.2%
$124.00
+2.9%
+53.3%$50.75B$7.78B20.612,932

Related Companies and Tools

This page (NYSE:AFL) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners